Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24433 | 312 | 18.1 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
260 | 3 | NUCL MED//RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING//JOURNAL OF NUCLEAR MEDICINE | 44690 |
1290 | 2 | SCINTIMAMMOGRAPHY//TECHNETIUM 99M//CLINICAL NUCLEAR MEDICINE | 8677 |
24433 | 1 | TC 99M V DMSA//BIOPHYS RADIOPHARMACEUT//PENTAVALENT TECHNETIUM 99M DIMERCAPTOSUCCINIC ACID | 312 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TC 99M V DMSA | authKW | 1617888 | 7% | 72% | 23 |
2 | BIOPHYS RADIOPHARMACEUT | address | 599447 | 2% | 88% | 7 |
3 | PENTAVALENT TECHNETIUM 99M DIMERCAPTOSUCCINIC ACID | authKW | 489346 | 2% | 100% | 5 |
4 | TCV DMS | authKW | 391477 | 1% | 100% | 4 |
5 | PENTAVALENT TC 99M DMSA | authKW | 313180 | 1% | 80% | 4 |
6 | EXTRARENAL UPTAKE | authKW | 293608 | 1% | 100% | 3 |
7 | PENTAVALENT TECHNETIUM 99M DMSA | authKW | 293608 | 1% | 100% | 3 |
8 | PH SENSITIVE AGENT | authKW | 293608 | 1% | 100% | 3 |
9 | RE 188V DMSA | authKW | 293608 | 1% | 100% | 3 |
10 | TC 99M GLUTATHIONE | authKW | 293608 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 10134 | 69% | 0% | 215 |
2 | Nuclear Science & Technology | 434 | 12% | 0% | 36 |
3 | Chemistry, Inorganic & Nuclear | 282 | 12% | 0% | 36 |
4 | Chemistry, Analytical | 106 | 9% | 0% | 29 |
5 | Otorhinolaryngology | 100 | 4% | 0% | 13 |
6 | Oncology | 12 | 5% | 0% | 17 |
7 | Biochemical Research Methods | 4 | 2% | 0% | 7 |
8 | Chemistry, Medicinal | 2 | 2% | 0% | 5 |
9 | Medicine, Research & Experimental | 2 | 2% | 0% | 7 |
10 | Surgery | 1 | 4% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOPHYS RADIOPHARMACEUT | 599447 | 2% | 88% | 7 |
2 | CELL SURVIVAL ADHES GRP | 195738 | 1% | 100% | 2 |
3 | PATHOFUNCT BIOANALSAKYO KU | 195738 | 1% | 100% | 2 |
4 | BESLENME DIYETETIK AD | 97869 | 0% | 100% | 1 |
5 | FUER RADIOPHARM | 97869 | 0% | 100% | 1 |
6 | GRP CELLULAR SURVIVAL ADHES TUMORS GRAFTS | 97869 | 0% | 100% | 1 |
7 | GRP EA 3063 CELLULAR SURVIVAL ADHES TUMOURS | 97869 | 0% | 100% | 1 |
8 | I33 | 97869 | 0% | 100% | 1 |
9 | INTERDISCIPLINARY STUDY AEROSOLIZED NANOPART | 97869 | 0% | 100% | 1 |
10 | LINA GRP EA 4624 | 97869 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL NUCLEAR MEDICINE | 83314 | 24% | 1% | 75 |
2 | NUCLEAR MEDICINE COMMUNICATIONS | 15944 | 8% | 1% | 26 |
3 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 7732 | 5% | 0% | 16 |
4 | JOURNAL OF NUCLEAR MEDICINE | 7549 | 9% | 0% | 28 |
5 | INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES | 4549 | 2% | 1% | 7 |
6 | RADIOCHEMISTRY | 3789 | 2% | 1% | 5 |
7 | NUKLEARMEDIZINER | 2641 | 1% | 1% | 2 |
8 | HELLENIC JOURNAL OF NUCLEAR MEDICINE | 2158 | 1% | 1% | 3 |
9 | NUCLEAR MEDICINE AND BIOLOGY | 1692 | 3% | 0% | 8 |
10 | INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY | 1328 | 1% | 1% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TC 99M V DMSA | 1617888 | 7% | 72% | 23 | Search TC+99M+V+DMSA | Search TC+99M+V+DMSA |
2 | PENTAVALENT TECHNETIUM 99M DIMERCAPTOSUCCINIC ACID | 489346 | 2% | 100% | 5 | Search PENTAVALENT+TECHNETIUM+99M+DIMERCAPTOSUCCINIC+ACID | Search PENTAVALENT+TECHNETIUM+99M+DIMERCAPTOSUCCINIC+ACID |
3 | TCV DMS | 391477 | 1% | 100% | 4 | Search TCV+DMS | Search TCV+DMS |
4 | PENTAVALENT TC 99M DMSA | 313180 | 1% | 80% | 4 | Search PENTAVALENT+TC+99M+DMSA | Search PENTAVALENT+TC+99M+DMSA |
5 | EXTRARENAL UPTAKE | 293608 | 1% | 100% | 3 | Search EXTRARENAL+UPTAKE | Search EXTRARENAL+UPTAKE |
6 | PENTAVALENT TECHNETIUM 99M DMSA | 293608 | 1% | 100% | 3 | Search PENTAVALENT+TECHNETIUM+99M+DMSA | Search PENTAVALENT+TECHNETIUM+99M+DMSA |
7 | PH SENSITIVE AGENT | 293608 | 1% | 100% | 3 | Search PH+SENSITIVE+AGENT | Search PH+SENSITIVE+AGENT |
8 | RE 188V DMSA | 293608 | 1% | 100% | 3 | Search RE+188V+DMSA | Search RE+188V+DMSA |
9 | TC 99M GLUTATHIONE | 293608 | 1% | 100% | 3 | Search TC+99M+GLUTATHIONE | Search TC+99M+GLUTATHIONE |
10 | HISTOLOGIC MALIGNANCY | 195738 | 1% | 100% | 2 | Search HISTOLOGIC+MALIGNANCY | Search HISTOLOGIC+MALIGNANCY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SEIFERT, S , SYHRE, R , SPIES, H , JOHANNSEN, B , (2003) NOVEL TUMORTROPIC ESTER DERIVATIVES OF TC-99M(V) MESODIMERCAPTO SUCCINIC ACID WITH LOW AFFINITY FOR BONE TISSUE.NUCLEAR MEDICINE COMMUNICATIONS. VOL. 24. ISSUE 11. P. 1175-1183 | 22 | 92% | 3 |
2 | BALCI, TA , CIFTCI, I , KARAOGLU, A , (2006) INCIDENTAL DTPA AND DMSA UPTAKE DURING RENAL SCANNING IN UNKNOWN BONE METASTASES.ANNALS OF NUCLEAR MEDICINE. VOL. 20. ISSUE 5. P. 365 -369 | 20 | 91% | 5 |
3 | AL-SAEEDI, FJ , MATHEW, PM , LUQMANI, YA , (2013) ASSESSMENT OF TRACER TC-99M(V)-DMSA UPTAKE AS A MEASURE OF TUMOR CELL PROLIFERATION IN VITRO.PLOS ONE. VOL. 8. ISSUE 1. P. - | 25 | 51% | 3 |
4 | KOTHARI, K , SATPATI, D , MUKHERJEE, A , SARMA, HD , VENKATESH, M , PILLAI, MRA , (2002) KIDNEY UPTAKE OF RE-186/188(V)-DMSA IS SIGNIFICANTLY REDUCED WHEN THE REDUCING AGENT IS CHANGED FROM STANNOUS ION TO METABISULFITE.JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. VOL. 45. ISSUE 8. P. 675-686 | 18 | 90% | 4 |
5 | STANIK, R , SVETLIK, J , BENKOVSKY, I , (2012) DMSA AND ITS COMPLEXES WITH RADIOISOTOPES: REVIEW.JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY. VOL. 293. ISSUE 2. P. 545-554 | 36 | 31% | 2 |
6 | LAM, ASK , PUNCHER, MRB , BLOWER, PJ , (1996) IN VITRO AND IN VIVO STUDIES WITH PENTAVALENT TECHNETIUM-99M DIMERCAPTOSUCCINIC ACID.EUROPEAN JOURNAL OF NUCLEAR MEDICINE. VOL. 23. ISSUE 12. P. 1575-1582 | 18 | 90% | 25 |
7 | LAM, ASK , KETTLE, AG , ODOHERTY, MJ , COAKLEY, AJ , BARRINGTON, SF , BLOWER, PJ , (1997) PENTAVALENT TC-99(M)-DMSA IMAGING IN PATIENTS WITH BONE METASTASES.NUCLEAR MEDICINE COMMUNICATIONS. VOL. 18. ISSUE 10. P. 907-914 | 20 | 77% | 27 |
8 | PARK, JY , LEE, TS , CHOI, TH , CHEON, GJ , CHOI, CW , AWH, OD , (2007) A COMPARATIVE STUDY OF RE-188(V)-MESO-DMSA AND RE-188(V)-RAC-DMSA: PREPARATION AND IN VIVO EVALUATION IN NUDE MICE XENOGRAFTED.NUCLEAR MEDICINE AND BIOLOGY. VOL. 34. ISSUE 8. P. 1029-1036 | 18 | 64% | 3 |
9 | YUKSEL, D , ILGAN, S , ARSLAN, N , UGUR, O , OZTURK, E , BAYHAN, H , (2000) THE ROLE OF TC-99M (V) DMSA SCINTIGRAPHY IN THE EVALUATION OF SUPERSCAN ON BONE SCINTIGRAPHY.CLINICAL NUCLEAR MEDICINE. VOL. 25. ISSUE 3. P. 193-196 | 16 | 89% | 5 |
10 | ERGUN, EL , KARA, PO , GEDIK, GK , KARS, A , TURKER, A , CANER, B , (2007) THE ROLE OF TC-99M (V) DMSA SCINTIGRAPHY IN THE DIAGNOSIS AND FOLLOW-UP OF LUNG CANCER LESIONS.ANNALS OF NUCLEAR MEDICINE. VOL. 21. ISSUE 5. P. 275 -283 | 15 | 75% | 9 |
Classes with closest relation at Level 1 |